November 06, 2025 a 08:00 am

ZTS: Fundamental Ratio Analysis - Zoetis Inc.

Zoetis Inc. - Animal Health Medicines and Diagnostics

Zoetis Inc. stands out in the animal health industry with a robust portfolio spanning medicinal and diagnostic products for both livestock and companion animals. Their strategic positioning in the healthcare sector promises stable growth opportunities. However, investors should weigh its medium-term volatility against long-term potential.

Fundamental Rating

The fundamental analysis of Zoetis showcases strong financial metrics, with notable strength in return metrics while facing challenges with its pricing multiples.

Category Score Visualization
Discounted Cash Flow 4
Return on Equity 5
Return on Assets 5
Debt to Equity 2
Price to Earnings 2
Price to Book 1

Historical Rating

The following table reveals consistency in Zoetis's financial performance, with negligible variations over the tracked period.

Date Overall Score DCF ROE ROA D/E P/E P/B
2025-11-05 3 4 5 5 2 2 1
Previous 0 4 5 5 2 2 1

Analyst Price Targets

Analyst consensus illustrates a favorable view on Zoetis with a "Buy" recommendation driven by promising price targets.

High Low Median Consensus
$215 $140 $158 $171
Zoetis Stock Performance Chart

Analyst Sentiment

The prevailing sentiment among analysts leans strongly towards purchase recommendations for Zoetis stock.

Recommendation Count Distribution
Strong Buy 1
Buy 16
Hold 13
Sell 0
Strong Sell 0

Conclusion

Zoetis Inc. exhibits a commendable balance between growth prospects and financial health, appealing to investors seeking exposure in the animal healthcare domain. With a favorable analyst consensus and competitive market standing, it is likely to sustain growth, albeit potential barriers such as market volatility and industry competition. Long-term investors might find appealing value in its strategic thrust, despite short-term unpredictabilities linked to economic cycles.